BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 24284513)

  • 1. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward.
    Levin A; Stevens PE
    Kidney Int; 2014 Jan; 85(1):49-61. PubMed ID: 24284513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Summary of KDIGO guideline: behind the scenes, need for guidance, and a framework for moving forward.
    Levin A; Stevens PE
    Kidney Int; 2013 May; ():. PubMed ID: 23715118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.
    Sarnak MJ; Bloom R; Muntner P; Rahman M; Saland JM; Wilson PW; Fried L
    Am J Kidney Dis; 2015 Mar; 65(3):354-66. PubMed ID: 25465166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.
    Stevens PE; Levin A;
    Ann Intern Med; 2013 Jun; 158(11):825-30. PubMed ID: 23732715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.
    Gorostidi M; Santamaría R; Alcázar R; Fernández-Fresnedo G; Galcerán JM; Goicoechea M; Oliveras A; Portolés J; Rubio E; Segura J; Aranda P; de Francisco AL; Del Pino MD; Fernández-Vega F; Górriz JL; Luño J; Marín R; Martínez I; Martínez-Castelao A; Orte LM; Quereda C; Rodríguez-Pérez JC; Rodríguez M; Ruilope LM
    Nefrologia; 2014 May; 34(3):302-16. PubMed ID: 24798565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Uhlig K; Berns JS; Kestenbaum B; Kumar R; Leonard MB; Martin KJ; Sprague SM; Goldfarb S
    Am J Kidney Dis; 2010 May; 55(5):773-99. PubMed ID: 20363541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries.
    Al Rukhaimi M; Al Sahow A; Boobes Y; Goldsmith D; Khabouth J; El Baz T; Mahmoud H; Ganji MR; Shaheen FA;
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):133-48. PubMed ID: 24434398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s).
    Drüeke TB; Parfrey PS
    Kidney Int; 2012 Nov; 82(9):952-60. PubMed ID: 22854645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness and implementation in daily practice of the S.E.N.-semFYC consensus document on chronic kidney disease.
    Egocheaga MI; Alcázar R; Lobos JM; Górriz JL; Martínez-Castelao A; Pastor A; Martínez I; Caballero F; Sánchez-Celaya M
    Nefrologia; 2012; 32(6):797-808. PubMed ID: 23169363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The elderly patient with low eGFR: beyond the numbers.
    Azar M
    R I Med J (2013); 2014 Dec; 97(12):19-23. PubMed ID: 25463622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S
    Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984
    [No Abstract]   [Full Text] [Related]  

  • 13. Referral and comanagement of the patient with CKD.
    Campbell GA; Bolton WK
    Adv Chronic Kidney Dis; 2011 Nov; 18(6):420-7. PubMed ID: 22098660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
    Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD.
    Ruzicka M; Quinn RR; McFarlane P; Hemmelgarn B; Ramesh Prasad GV; Feber J; Nesrallah G; MacKinnon M; Tangri N; McCormick B; Tobe S; Blydt-Hansen TD; Hiremath S
    Am J Kidney Dis; 2014 Jun; 63(6):869-87. PubMed ID: 24725980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
    Gordon CE; Balk EM; Becker BN; Crooks PA; Jaber BL; Johnson CA; Michael MA; Pereira BJ; Uhlig K; Levin A
    Am J Kidney Dis; 2008 Nov; 52(5):811-25. PubMed ID: 18971009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines.
    Weckmann GFC; Stracke S; Haase A; Spallek J; Ludwig F; Angelow A; Emmelkamp JM; Mahner M; Chenot JF
    BMC Nephrol; 2018 Oct; 19(1):258. PubMed ID: 30305035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline.
    Navaneethan SD; Zoungas S; Caramori ML; Chan JCN; Heerspink HJL; Hurst C; Liew A; Michos ED; Olowu WA; Sadusky T; Tandon N; Tuttle KR; Wanner C; Wilkens KG; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli M; Cheung M; Earley A; Rossing P; de Boer IH; Khunti K
    Ann Intern Med; 2021 Mar; 174(3):385-394. PubMed ID: 33166222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of the 2018 Kidney Disease Improving Global Outcomes (KDIGO) Guideline on hepatitis C in chronic kidney disease.
    Gordon CE; Balk EM; Francis JM
    Semin Dial; 2019 Mar; 32(2):187-195. PubMed ID: 30496617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.
    Moist LM; Troyanov S; White CT; Wazny LD; Wilson JA; McFarlane P; Harwood L; Sood MM; Soroka SD; Bass A; Manns BJ
    Am J Kidney Dis; 2013 Nov; 62(5):860-73. PubMed ID: 24054466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.